Clinical value of 68Ga-DOTA-SSTR PET/CT in the diagnosis and detection of neuroendocrine tumors of unknown primary origin: a systematic review and meta-analysis

Volume: 62, Issue: 9, Pages: 1217 - 1228
Published: Sep 26, 2020
Abstract
Background The ability of 68 Ga-DOTA-SSTR to detect the primary sites of neuroendocrine tumors (NETs) remains undetermined, and the clinical benefit of this imaging agent is not clear. Purpose To evaluate the diagnostic accuracy of 68 Ga-DOTA-SSTR for carcinoma unknown primary (CUP) neuroendocrine tumors and to further analyze the detection rate of 68 Ga-DOTA-SSTR for primary and metastatic sites. Material and Methods A comprehensive literature...
Paper Details
Title
Clinical value of 68Ga-DOTA-SSTR PET/CT in the diagnosis and detection of neuroendocrine tumors of unknown primary origin: a systematic review and meta-analysis
Published Date
Sep 26, 2020
Volume
62
Issue
9
Pages
1217 - 1228
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.